Pleural effusions following cardiac injury and coronary artery bypass graft surgery

R W Light1

  • 1Saint Thomas Hospital, Nashville, Tennessee 37205, USA. RLIGHT98@yahoo.com

Insights

Post-cardiac injury syndrome and coronary artery bypass graft surgery can cause pleural effusions. Treatment varies, with NSAIDs or corticosteroids for PCIS and thoracentesis for CABG-related effusions.

Area of Science:

  • Cardiology
  • Pulmonology
  • Internal Medicine

Background:

  • Pleural effusions are a known complication following cardiac injury and surgery.
  • Distinguishing between effusions from post-cardiac injury syndrome (PCIS) and coronary artery bypass graft (CABG) surgery is clinically important.

Purpose of the Study:

  • To compare and contrast pleural effusions associated with PCIS and those occurring after CABG surgery.
  • To outline the typical presentation, characteristics, and management strategies for each type of effusion.

Main Methods:

  • Review of clinical presentations and characteristics of pleural effusions in PCIS and post-CABG patients.
  • Analysis of the timing, fluid composition, and symptoms associated with each type of effusion.
  • Discussion of established treatment protocols for both conditions.

Main Results:

  • PCIS-related effusions are associated with fever, chest pain, and pericarditis, often treated with anti-inflammatory agents or corticosteroids.
  • Post-CABG effusions are typically unilateral and left-sided; early effusions are bloody with eosinophils, while late effusions are lymphocytic.
  • Dyspnea is the primary symptom for post-CABG effusions, which are often managed with therapeutic thoracentesis.

Conclusions:

  • Pleural effusions in PCIS and post-CABG surgery have distinct clinical features and etiologies.
  • Understanding these differences guides appropriate diagnosis and management, improving patient outcomes.

Related Concept Videos

Pleural Effusion I: Introduction01:25

Pleural Effusion I: Introduction

Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pulmonary Edema II: Pathophysiology01:18

Pulmonary Edema II: Pathophysiology

Pulmonary edema is the accumulation of fluid in the interstitial and alveolar spaces of the lungs, impairing gas exchange and oxygen delivery. It may be cardiogenic or noncardiogenic, but both reduce oxygenation and lung compliance.Cardiogenic Pulmonary EdemaCardiogenic edema results from increased hydrostatic pressure in pulmonary capillaries, usually due to left ventricular dysfunction from myocardial infarction, heart failure, or valvular disease. Ineffective cardiac pumping causes blood to...
Pneumothorax-II01:27

Pneumothorax-II

Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Pericarditis II: Clinical Features and Diagnostic Tests01:19

Pericarditis II: Clinical Features and Diagnostic Tests

Pericarditis is distinguished by inflammation of the pericardium, the fibrous sac that encases the heart. It can be acute, lasting less than six weeks, or chronic, persisting for over three months. Understanding its clinical manifestations and diagnostic findings is crucial for timely and effective management.Clinical ManifestationsWhile pericarditis can be asymptomatic, it usually presents with characteristic symptoms such as:Chest Pain: The most characteristic symptom of pericarditis is chest...
Pericarditis III: Medical Management01:17

Pericarditis III: Medical Management

The primary objectives of managing pericarditis are to determine the underlying cause, provide effective therapy for treatment and symptom relief, and promptly detect signs and symptoms of cardiac tamponade. The following outlines the essential aspects of medical management for pericarditis:ObjectivesDetermine the Cause: Identifying the underlying cause of pericarditis is crucial for targeted treatment. Causes include viral infections, autoimmune diseases, post-cardiac injury syndrome, and...